D2OC34 Stock Overview
Operates a cloud-based digital platform for medical professionals in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Doximity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$46.40 |
| 52 Week High | US$58.74 |
| 52 Week Low | US$19.99 |
| Beta | 1.3 |
| 11 Month Change | 18.97% |
| 3 Month Change | 41.64% |
| 1 Year Change | 128.80% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| D2OC34 | BR Healthcare Services | BR Market | |
|---|---|---|---|
| 7D | -8.2% | 0% | 0% |
| 1Y | 128.8% | 0% | 0% |
Return vs Industry: D2OC34 exceeded the BR Healthcare Services industry which returned 5.2% over the past year.
Return vs Market: D2OC34 exceeded the BR Market which returned -0.3% over the past year.
Price Volatility
| D2OC34 volatility | |
|---|---|
| D2OC34 Average Weekly Movement | 12.4% |
| Healthcare Services Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: D2OC34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine D2OC34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 827 | Jeff Tangney | www.doximity.com |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.
Doximity, Inc. Fundamentals Summary
| D2OC34 fundamental statistics | |
|---|---|
| Market cap | R$52.24b |
| Earnings (TTM) | R$1.01b |
| Revenue (TTM) | R$3.00b |
51.7x
P/E Ratio17.4x
P/S RatioIs D2OC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| D2OC34 income statement (TTM) | |
|---|---|
| Revenue | US$516.85m |
| Cost of Revenue | US$51.98m |
| Gross Profit | US$464.87m |
| Other Expenses | US$290.76m |
| Earnings | US$174.11m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 89.94% |
| Net Profit Margin | 33.69% |
| Debt/Equity Ratio | 0% |
How did D2OC34 perform over the long term?
See historical performance and comparison